假肢内心炎管理方面的进展和挑战:一篇综述
1Department of Cardiac Surgery, Centre Cardiologique du Nord, 93200 Saint-Denis, France.
Pathogens (Basel, Switzerland)
|January 8, 2025
概括
假内心炎 (PVE) 是一个越来越令人担忧的疾病,特别是在老年患者和那些有过导管的患者中. 新的诊断工具提高了检测,但迫切需要更多的研究来对抗这种危及生命的感染.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 医学诊断 医学诊断 医学诊断
背景情况:
- 假肢内心炎 (PVE) 影响着老龄化人口群体,并且越来越多地出现在通过导管植入的患者中.
- 黄金葡萄球菌是发达国家的主要病因,导致侵袭性疾病,而菌菌种在TAVR后带来了挑战.
- 由于有限的研究,资金和缺乏随机对照试验,对PVE的理解仍然存在重大差距.
研究的目的:
- 突出演变的流行病学和假内心炎 (PVE) 的挑战.
- 强调更新诊断标准和新兴治疗策略的重要性.
- 要强调在管理PVE方面迫切需要进一步的研究和多学科的护理.
主要方法:
- 在过去的五十年中对PVE的流行病学趋势的审查.
- 纳入先进的诊断技术,包括-18氧葡萄糖正子发射断层扫描和计算机断层扫描,到2023年杜克/ICD标准.
- 分析当前的治疗方法,包括创新的手术技术和门诊抗菌疗法.
主要成果:
- PVE流行病学显示,人们正在转向老年患者和透导管门.
- 新的成像和微生物学技术显著提高了PVE诊断的敏感性和特异性.
- 多学科团队管理和不断发展的治疗策略旨在改善患者的治疗结果.
结论:
- 假内心炎 (PVE) 需要紧急注意,因为人口结构和致病生物的变化.
- 像PET/CT这样的先进诊断技术改善了PVE检测,与更新的指南保持一致.
- 进一步的研究,包括随机试验,对于解决PVE管理缺口和优化患者护理至关重要.
相关概念视频
01:22Healthcare Associated Infections II: Preventive Measures
2.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.4K
01:28Esophageal Perforation-II: Clinical Manifestations and Management
43
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
43
01:28Pneumonia IV: Management
298
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298